Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2025 15:13 ET | Source: The Lundquist Institute for Biomedical Innovation

The Lundquist Institute Awarded $9 Million to Launch Community Center of Excellence for Regenerative Medicine

Torrance, CA, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Christina Wang, MD, and Lynda Polgreen, MD, MS, investigators at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, have...
October 08, 2025 08:18 ET | Source: Science 37, Inc.

Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial

Science 37 announces the successful completion of its third FDA inspection with a No Action Indicated (NAI) categorization.
September 04, 2025 08:00 ET | Source: Science 37, Inc.

Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Research

Science 37 and Catalent announce a strategic partnership enabling direct-to-patient investigational medicinal product (IMP) delivery for clinical research.
July 25, 2025 08:30 ET | Source: Intelligent Bio Solutions, Inc.

Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds

NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
May 05, 2025 16:05 ET | Source: Biomea Fusion, Inc.

Biomea Fusion Reports First Quarter 2025 Financial Results and Corporate Highlights

Company Announces Strategic Realignment to Focus on Core Programs and Extend Cash Runway Icovamenib progressing toward the next phase of clinical development in insulin deficient type 2 diabetes...
April 08, 2025 08:15 ET | Source: Autonomix Medical, Inc.

Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain

Company on track to commence U.S. clinical studies in 2025 to support a De Novo application for FDA approval THE WOODLANDS, TX, April 08, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ:...
January 14, 2025 08:00 ET | Source: Science 37, Inc.

Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation

Science 37 announces the appointment of Tyler Van Horn as Chief Executive Officer.
November 26, 2024 08:30 ET | Source: Intelligent Bio Solutions, Inc.

Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results

Intelligent Fingerprinting Drug Screening System on path to FDA 510(k) submission, expected in the fourth calendar quarter of 2024 INBS will include data from recent PK study alongside results of...
November 13, 2024 08:30 ET | Source: Intelligent Bio Solutions, Inc.

Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission

PK Study Successfully Demonstrates that Fingerprint Sweat Provides Reliable Sample for Drug Detection FDA 510(k) Clearance Would Enable the Introduction of INBS’ Technology to the US in 2025 NEW...
October 23, 2024 09:00 ET | Source: Alkeus Pharmaceuticals

Topline Results from Alkeus Pharmaceuticals’ Study of Oral Gildeuretinol Demonstrate Significant Trend in Slowing GA Progression and Visual Function Improvement

Alkeus Pharmaceuticals, Inc., today announced that results from its study of gildeuretinol in geographic atrophy were presented at AAO 2024.